ITGA2B and ischemic stroke: In addition, clinical trials of other types of antiplatelet drugs such as adenosine diphosphate (ADP) receptor antagonist (ticagrelor)37, 38 and glycoprotein IIb/IIIa (GPIIb/IIIa) receptor antagonist (tirofiban)39 were also undergoing or completed, which revealed new information on the treatment of ischemic stroke.